The FY2025 (Dec) proxy of Cartesian Therapeutics names 19 peer companies for pay. Among Cartesian Therapeutics and these peers, CEO pay was 6th highest of 12 and total shareholder return was 10th highest of 12.
6th highest of 12in Cartesian Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$2.1M$27.8M
10th highest of 12in Cartesian Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
$18$906
Pay peer group, FY2025 (Dec) proxy
| Cogent Biosciences | ||
| MeiraGTx Holdings | ||
| Corvus Pharmaceuticals | ||
| Anaptysbio | ||
| Savara | ||
| Regenxbio | ||
| Replimune Group | ||
| Annexon | ||
| Rocket Pharmaceuticals | ||
| Lineage Cell Therapeutics | ||
| 4D Molecular Therapeutics | ||
| Alector | Not disclosed | Not disclosed |
| Allogene Therapeutics | Not disclosed | Not disclosed |
| Cabaletta Bio | Not disclosed | Not disclosed |
| Candel Therapeutics | Not disclosed | Not disclosed |
| Macrogenics | Not disclosed | Not disclosed |
| Rezolute | Not disclosed | Not disclosed |
| Viridian Therapeutics | Not disclosed | Not disclosed |
| Vor Biopharma | Not disclosed | Not disclosed |
19 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.